Effects of central apneas on sympathovagal balance and hemodynamics at night: impact of underlying systolic heart failure.


Journal

Sleep & breathing = Schlaf & Atmung
ISSN: 1522-1709
Titre abrégé: Sleep Breath
Pays: Germany
ID NLM: 9804161

Informations de publication

Date de publication:
06 2021
Historique:
received: 03 01 2020
accepted: 09 07 2020
revised: 08 06 2020
pubmed: 24 7 2020
medline: 18 12 2021
entrez: 24 7 2020
Statut: ppublish

Résumé

Increased sympathetic drive is the key determinant of systolic heart failure progression, being associated with worse functional status, arrhythmias, and increased mortality. Central sleep apnea is highly prevalent in systolic heart failure, and its effects on sympathovagal balance (SVB) and hemodynamics might depend on relative phase duration and background pathophysiology. This study compared the effects of central apneas in patients with and without systolic heart failure on SVB and hemodynamics during sleep. During polysomnography, measures of SVB (heart rate and diastolic blood pressure variability) were non-invasively recorded and analyzed along with baroreceptor reflex sensitivity and hemodynamic parameters (stroke volume index, cardiac index, total peripheral resistance index). Data analysis focused on stable non-rapid eye movement N2 sleep, comparing normal breathing with central sleep apnea in subjects with and without systolic heart failure. Ten patients were enrolled per group. In heart failure patients, central apneas had neutral effects on SVB (all p > 0.05 for the high, low, and very low frequency components of heart rate and diastolic blood pressure variability). Patients without heart failure showed an increase in very low and low frequency components of diastolic blood pressure variability in response to central apneas (63 ± 18 vs. 39 ± 9%; p = 0.001, 43 ± 12 vs. 31 ± 15%; p = 0.002). In all patients, central apneas had neutral hemodynamic effects when analyzed over a period of 10 min, but had significant acute hemodynamic effects. Effects of central apneas on SVB during sleep depend on underlying systolic heart failure, with neutral effects in heart failure and increased sympathetic drive in idiopathic central apneas.

Sections du résumé

BACKGROUND
Increased sympathetic drive is the key determinant of systolic heart failure progression, being associated with worse functional status, arrhythmias, and increased mortality. Central sleep apnea is highly prevalent in systolic heart failure, and its effects on sympathovagal balance (SVB) and hemodynamics might depend on relative phase duration and background pathophysiology.
OBJECTIVE
This study compared the effects of central apneas in patients with and without systolic heart failure on SVB and hemodynamics during sleep.
METHODS
During polysomnography, measures of SVB (heart rate and diastolic blood pressure variability) were non-invasively recorded and analyzed along with baroreceptor reflex sensitivity and hemodynamic parameters (stroke volume index, cardiac index, total peripheral resistance index). Data analysis focused on stable non-rapid eye movement N2 sleep, comparing normal breathing with central sleep apnea in subjects with and without systolic heart failure.
RESULTS
Ten patients were enrolled per group. In heart failure patients, central apneas had neutral effects on SVB (all p > 0.05 for the high, low, and very low frequency components of heart rate and diastolic blood pressure variability). Patients without heart failure showed an increase in very low and low frequency components of diastolic blood pressure variability in response to central apneas (63 ± 18 vs. 39 ± 9%; p = 0.001, 43 ± 12 vs. 31 ± 15%; p = 0.002). In all patients, central apneas had neutral hemodynamic effects when analyzed over a period of 10 min, but had significant acute hemodynamic effects.
CONCLUSION
Effects of central apneas on SVB during sleep depend on underlying systolic heart failure, with neutral effects in heart failure and increased sympathetic drive in idiopathic central apneas.

Identifiants

pubmed: 32700287
doi: 10.1007/s11325-020-02144-8
pii: 10.1007/s11325-020-02144-8
pmc: PMC8195752
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

965-977

Subventions

Organisme : Else Kröner-Fresenius-Stiftung
ID : A 109

Références

Oldenburg O, Lamp B, Faber L, Teschler H, Horstkotte D, Töpfer V (2007) Sleep-disordered breathing in patients with symptomatic heart failure. A contemporary study of prevalence in and characteristics of 700 patients. Eur J Heart Fail 9:251–257
pubmed: 17027333
Lanfranchi PA, Somers VK, Braghiroli A, Corra U, Eleuteri E, Giannuzzi P (2003) Central sleep apnea in left ventricular dysfunction: prevalence and implications for arrhythmic risk. Circulation 107:727–732
pubmed: 12578876
Emdin M, Mirizzi G, Giannoni A, Poletti R, Iudice G, Bramanti F, Passino C (2017) Prognostic significance of central apneas throughout a 24-hour period in patients with heart failure. J Am Coll Cardiol 70:1351–1364
pubmed: 28882233
Kara T, Narkiewicz K, Somers VK (2003) Chemoreflexes-physiology and clinical implications. Acta Physiol Scand 177:377–384
pubmed: 12609009
Spiesshoefer J, Spieker M, Klose et al (2019) Reduction of sleep-disordered breathing following effective percutaneous mitral valve repair with the MitraClip system. Sleep Breath 23:815–824
pubmed: 30523557
Solin P, Kaye DM, Little PJ et al (2003) Impact of sleep apnea on sympathetic nervous system activity in heart failure. Chest 123:1119–1126
pubmed: 12684302
Giannoni A, Raglianti V, Mirizzi G, Taddei C, del Franco A, Iudice G, Bramanti F, Aimo A, Pasanisi E, Emdin M, Passino C (2016) Influence of central apneas and chemo reflex activation on pulmonary artery pressure in chronic heart failure. Int J Cardiol 202:200–206
pubmed: 26397412
Giannoni A, Raglianti V, Taddei C, Borrelli C, Chubuchny V, Vergaro G, Mirizzi G, Valleggi A, Cameli M, Pasanisi E, Emdin M, Passino C (2019) Cheyne-Stokes respiration related oscillations in cardiopulmonary hemodynamics in patients with heart failure. Int J Cardiol 289:76–82
pubmed: 30917898
Floras JS (2009) Sympathetic nervous system activation in human heart failure. Clinical implications of an updated model. J Am Coll Cardiol 54:375–385
pubmed: 19628111
Ponikowski P, Voors A, Anker S, Bueno H, Cleland JGF, Coats AJS, Falk V, González-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GMC, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P, ESC Scientific Document Group (2016) 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 37:2129–2200
pubmed: 27206819
Lorenzi-Filho G, Rankin F, Bies I, Douglas Bradley T (1999) Effects of inhaled carbon dioxide and oxygen on Cheyne-Stokes respiration in patients with heart failure. Am J Respir Crit Care Med 159:1490–1498
pubmed: 10228116
Giannoni A, Baruah R, Willson K, Mebrate Y, Mayet J, Emdin M, Hughes AD, Manisty CH, Francis DP (2010) Real-time dynamic carbon dioxide administration a novel treatment strategy for stabilization of periodic breathing with potential application to central sleep apnea. J Am Coll Cardiol 56:1832–1837
pubmed: 21087712
Schumacher DS, Müller-Mottet S, Hasler ED et al (2014) Effect of oxygen and acetazolamide on nocturnal cardiac conduction, repolarization, and arrhythmias in precapillary pulmonary hypertension and sleep-disturbed breathing. Chest 146:1226–1236
pubmed: 24991933
Fontana M, Emdin M, Giannoni A, Iudice G, Baruah R, Passino C (2011) Effect of acetazolamide on chemosensitivity, Cheyne-Stokes respiration, and response to effort in patients with heart failure. Am J Cardiol 107:1675–1680
pubmed: 21420051
Javaheri S (2006) Acetazolamide improves central sleep apnea in heart failure: a double-blind, prospective study. Am J Respir Crit Care Med 173:234–237
pubmed: 16239622
Naughton MT, Benard DC, Liu PP, Rutherford R, Rankin FBT (1995) Effects of nasal CPAP on sympathetic activity in patients with heart failure and central sleep apnea. Am J Respir Crit Care Med 152:473–479
pubmed: 7633695
Koyama T, Watanabe H, Tamura Y, Oguma Y, Kosaka T, Ito H (2013) Adaptive servo-ventilation therapy improves cardiac sympathetic nerve activity in patients with heart failure. Eur J Heart Fail 15:902–909
pubmed: 23504594
Joho S, Oda Y, Ushijima R, Hirai T, Inoue H (2012) Effect of adaptive servoventilation on muscle sympathetic nerve activity in patients with chronic heart failure and central sleep apnea. J Card Fail 18:769–775
pubmed: 23040112
Cowie MR, Woehrle H, Wegscheider K et al (2018) Adaptive servo-ventilation for central sleep apnoea in systolic heart failure : results of the major substudy of SERVE-HF. Eur J Heart Fail 20:536–544
pubmed: 29193576
Mehra R, Gottlieb DJ (2015) A paradigm shift in the treatment of central sleep apnea in heart failure. Chest 148:848–851
pubmed: 26258890
Linz D, Fox H, Bitter T et al (2016) Impact of SERVE-HF on management of sleep disordered breathing in heart failure: a call for further studies. Clin Res Cardiol 105:563–570
pubmed: 26872963
Naughton MT (2012) Cheyne–Stokes respiration: friend or foe? Thorax 67:357–360
pubmed: 22318163
Oldenburg O, Spießhöfer J, Fox H et al (2015) Cheyne-Stokes respiration in heart failure: friend or foe? Hemodynamic effects of hyperventilation in heart failure patients and healthy volunteers. Clin Res Cardiol 104:328–333
pubmed: 25373383
Muza RT (2015) Central sleep apnoea-a clinical review. J Thorac Dis 7:930–937
pubmed: 26101651 pmcid: 4454847
Solin P, Roebuck T, Johns DP, Walters EH, Naughton MT (2000) Peripheral and central ventilatory responses in central sleep apnea with and without congestive heart failure. Am J Respir Crit Care Med 162:2194–2200
pubmed: 11112137
Baumgartner H, Falk V, Bax JJ et al (2017) 2017 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J 38:2739–2786
pubmed: 28886619
Fortin J, Habenbacher W, Heller A, Hacker A, Grüllenberger R, Innerhofer J, Passath H, Wagner Ch, Haitchi G, Flotzinger D, Pacher R, Wach P (2006) Non-invasive beat-to-beat cardiac output monitoring by an improved method of transthoracic bioimpedance measurement. Comput Biol Med 36:1185–1203
pubmed: 16131462
Fortin J, Marte W, Grüllenberger R, Hacker A, Habenbacher W, Heller A, Wagner Ch, Wach P, Skrabal F (2006) Continuous non-invasive blood pressure monitoring using concentrically interlocking control loops. Comput Biol Med 36:941–957
pubmed: 16483562
Spießhöfer J, Fox H, Lehmann R et al (2016) Heterogenous haemodynamic effects of adaptive servoventilation therapy in sleeping patients with heart failure and Cheyne–Stokes respiration compared to healthy volunteers. Heart Vessel 31:1117–1130
Gratze G, Fortin J, Holler A, Grasenick K, Pfurtscheller G, Wach P, Schönegger J, Kotanko P, Skrabal F (1998) A software package for non-invasive, real-time beat-to-beat monitoring of stroke volume, blood pressure, total peripheral resistance and for assessment of autonomic function. Comput Biol Med 28:121–142
pubmed: 9684089
Nakata A, Takata S, Yuasa T et al (1998) Spectral analysis of heart rate, arterial pressure, and muscle sympathetic nerve activity in normal humans. Power 274:1211–1217
Guidelines (1996) Guidelines Heart rate variability. Eur Heart J 17:354–381
Carrasco-Sosa S, Gaitán-González MJ, González-Camarena R, Yáñez-Suárez O (2005) Baroreflex sensitivity assessment and heart rate variability: relation to maneuver and technique. Eur J Appl Physiol 95:265–275
pubmed: 16086148
Davies LC, Francis D, Jurák P et al (1999) Reproducibility of methods for assessing baroreflex sensitivity in normal controls and in patients with chronic heart failure. Clin Sci (Lond) 97:515–522
Berry RB, Gamaldo CE, Harding SM, Lloyd RM, Marcus CL, Vaughn BV, for the American Academy of Sleep Medicine BR (2012) The AASM manual for the scoring of sleep and associated events. J Clin Sleep Med 8:597–619
pubmed: 23066376 pmcid: 3459210
Spiesshoefer J, Becker S, Tuleta I, Mohr M, Diller GP, Emdin M, Florian AR, Yilmaz A, Boentert M, Giannoni A (2019) Impact of simulated hyperventilation and periodic breathing on sympatho-vagal balance and hemodynamics in patients with and without heart failure. Respiration 98:482–494
pubmed: 31461730
Gorbachevski M, Spiesshoefer J, Arzt M et al (2020) Adaptive servo-ventilation therapy does not favourably alter sympatho-vagal balance in sleeping patients with systolic heart failure and central apnoeas: preliminary data. Int J Cardiol. https://doi.org/10.1016/j.ijcard.2020.03.078
Karemaker JM (2017) An introduction into autonomic nervous function. Physiol Meas 38:89–118
Penzel T, Wessel N, Riedl M et al (2007) Cardiovascular and respiratory dynamics during normal and pathological sleep. Chaos 17:015116
pubmed: 17411273
Poletti R, Passino C, Giannoni A, Zyw L, Prontera C, Bramanti F, Clerico A, Piepoli M, Emdin M (2009) Risk factors and prognostic value of daytime Cheyne–Stokes respiration in chronic heart failure patients. Int J Cardiol 137:47–53
pubmed: 18691782
Mansfield D, Kaye DM, La Rocca HB et al (2003) Raised sympathetic nerve activity in heart failure and central sleep apnea is due to heart failure severity. Circulation 107:1396–1400
pubmed: 12642360
Maze SS, Kotler MN, Parry WR (1989) Doppler evaluation of changing cardiac dynamics during Cheyne-Stokes respiration. Chest 95:525–529
pubmed: 2920578
Xie A, Wong B, Phillipson EA et al (1994) Interaction of hyperventilation and arousal in the pathogenesis of idiopathic central sleep apnea. Am J Respir Crit Care Med 150:489–495
pubmed: 8049835
Van de Borne P, Montano N, Zimmerman B et al (1997) Relationship between repeated measures of hemodynamics, muscle sympathetic nerve activity, and their spectral oscillations. Circulation 96:4326–4332
pubmed: 9416900
Kienzle MG, Ferguson DW, Birkett CL et al (1992) Clinical, hemodynamic and sympathetic neural correlates of heart rate variability in congestive heart failure. Am J Cardiol 69:761–767
pubmed: 1546651
Türoff A, Thiem U, Fox H, Spießhöfer J, Bitter T, Tamisier R, Punjabi NM, Horstkotte D, Oldenburg O (2017) Sleep duration and quality in heart failure patients. Sleep Breath 21:919–927
pubmed: 28389910
Burnum JF, Hickam JB, McIntosh HD (1954) The effect of hypocapnia on arterial blood pressure. Circulation 9:89–95
pubmed: 13116381

Auteurs

Jens Spiesshoefer (J)

Institute of Life Sciences, Scuola Superiore Sant'Anna, Piazza Martiri della Libertà, 33, 56127, Pisa, PI, Italy. j.spiesshoefer@santannapisa.it.
Department of Neurology with Institute for Translational Neurology, University of Muenster, Muenster, Germany. j.spiesshoefer@santannapisa.it.

Nora Hegerfeld (N)

Department of Neurology with Institute for Translational Neurology, University of Muenster, Muenster, Germany.

Malte Frank Gerdes (MF)

Faculty of Mathematics and Computer Science, University Muenster, Muenster, Germany.

Sören Klemm (S)

Faculty of Mathematics and Computer Science, University Muenster, Muenster, Germany.

Martha Gorbachevski (M)

Department of Neurology with Institute for Translational Neurology, University of Muenster, Muenster, Germany.

Robert Radke (R)

Department of Cardiology III, University Hospital Muenster, Muenster, Germany.

Izabela Tuleta (I)

Department of Cardiology I, University Hospital Muenster, Muenster, Germany.

Claudio Passino (C)

Institute of Life Sciences, Scuola Superiore Sant'Anna, Piazza Martiri della Libertà, 33, 56127, Pisa, PI, Italy.
Cardiology and Cardiovascular Medicine Division, Fondazione Toscana Gabriele Monasterio, National Research Council, CNR-Regione Toscana, Pisa, Italy.

Xiaoyi Jiang (X)

Faculty of Mathematics and Computer Science, University Muenster, Muenster, Germany.

Paolo Sciarrone (P)

Cardiology and Cardiovascular Medicine Division, Fondazione Toscana Gabriele Monasterio, National Research Council, CNR-Regione Toscana, Pisa, Italy.

Winfried Randerath (W)

Bethanien Hospital gGmbH, Solingen, Germany.
Institute for Pneumology at the University of Cologne, Solingen, Germany.

Michael Dreher (M)

Department of Pneumology and Intensive Care Medicine, University Hospital RWTH, Aachen, Germany.

Matthias Boentert (M)

Department of Neurology with Institute for Translational Neurology, University of Muenster, Muenster, Germany.
Department of Medicine, UKM Marienhospital, Steinfurt, Germany.

Alberto Giannoni (A)

Institute of Life Sciences, Scuola Superiore Sant'Anna, Piazza Martiri della Libertà, 33, 56127, Pisa, PI, Italy.
Cardiology and Cardiovascular Medicine Division, Fondazione Toscana Gabriele Monasterio, National Research Council, CNR-Regione Toscana, Pisa, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH